Blough, Michael D <br/><br/>
Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor initiating cells from glioblastoma.  [electronic resource] 

 -  Journal of neuro-oncology  Mar 2011 
 - 1-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-7373 
<br/><br/><label>Standard No.: </label>10.1007/s11060-010-0283-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Alkylating--pharmacology<br/>Blotting, Western<br/>Brain Neoplasms--drug therapy<br/>DNA Methylation<br/>Dacarbazine--analogs & derivatives<br/>Drug Resistance, Neoplasm--genetics<br/>Glioma--drug therapy<br/>Humans<br/>Mutation--genetics<br/>Neoplastic Stem Cells--drug effects<br/>O(6)-Methylguanine-DNA Methyltransferase--metabolism<br/>Promoter Regions, Genetic--genetics<br/>RNA, Messenger--genetics<br/>RNA, Small Interfering--genetics<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Temozolomide<br/>Tumor Cells, Cultured<br/>Tumor Suppressor Protein p53--antagonists & inhibitors